Expectorant Drugs Market Poised to Reach US$22.9 Billion by 2030 with a Steady 4.5% CAGR | Persistence Market Research
23. Januar 2024 04:30 ET
|
Persistence Market Research
New York, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Market Size & Overview: The global expectorant drugs market is projected to grow at a robust CAGR of 4.5%, surging from US$16.8 billion in 2023 to...
Hypersensitivity Pneumonitis Market Size Projections Exhibit a CAGR of 4.56%, Likely to Attain a Value of USD 1254.83 Million by 2030
03. Oktober 2023 08:14 ET
|
Zion Market Research
NEW YORK, United States, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Hypersensitivity Pneumonitis Market By Source Of Exposure (Occupational...
Steering committee of pulmonary and primary care experts aims to reduce time to diagnose complex lung diseases
17. Mai 2022 10:00 ET
|
American College of Chest Physicians
GLENVIEW, Ill., May 17, 2022 (GLOBE NEWSWIRE) -- The American College of Chest Physicians (CHEST) and Three Lakes Foundation are announcing a steering committee of experts in the fields of pulmonary...
Betterbrand's Retail Migration Begins at Earthbar
10. September 2021 09:00 ET
|
The Better Brand Inc
NEWPORT BEACH, Calif., Sept. 10, 2021 (GLOBE NEWSWIRE) -- For the past fifty years, Earthbar® has cemented itself as the preeminent Health and Wellness retailer in Southern California. Consumers can...
MATEON PARTNERED WITH CHOPRA FOUNDATION ON ARTIVEDA™
16. Februar 2021 09:52 ET
|
Mateon Therapeutics, Inc.
AGOURA HILLS, California, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious disease and...
Strados Labs Adds Health Leaders to Management Team
12. Februar 2019 00:00 ET
|
Strados Labs
PHILADELPHIA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Strados Labs, creator of the world’s first remote respiratory monitoring platform, announced today the addition of three new executives to its...